Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Stocks like Jio Financial Services, Can Fin Homes, Seshasayee Paper, Supreme Petrochem, 5paisa Capital, ICICI Lombard General ...

Indian markets closed on a positive note on Monday with the 30-share Sensex gaining 454 points or 0.59 per cent to settle at ...

Even as the global diabetes war continues to rage, Indian pharmaceutical companies are emerging from the shadows, armed with ...

The initial burst of new launches by Sun, Cipla, Zydus and Lupin are in the mid-to-late stage of product lifecycle. However, the industry as a whole has been downplaying the threat from trade ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.

The edible oils segment of Adani Wilmar saw consumer downtrading, but the company retained its market share through a diverse brand portfolio across price points. In the foods category, key packaged ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ahmedabad: Zydus Wellness Products Limited, a wholly owned subsidiary of Zydus Wellness, has received a GST demand of Rs 56.33 crores along with applicable interest and penalty from the tax authority.

Zydus Wellness Ltd announced that its subsidiary, Zydus Wellness Products Ltd, has received a GST demand of Rs 56.33 crore with interest and penalties from the tax authority. The demand relates to ...

In September 2024, Zydus Lifesciences intimated about execution of Business ... The Company and SBL have today, i.e. 27 December 2024, executed a letter to extend the date of completion as above. In ...